Top Neurosurgeon Explains How Functional Neurosurgery Treatments are Helping Patients Suffering from Pain, Epilepsy, Spasticity and Movement Disorders
Atlantic NeuroSurgical Specialists’ (ANS) neurosurgeon, Dr Zampella, discusses new treatment options for chronic neurosurgical illnesses within functional neurosurgery.
Morristown, NJ (PRWEB) February 28, 2014
Atlantic NeuroSurgical Specialists (ANS) announced today advanced treatment options for their patients through Functional neurosurgery. Functional neurosurgery consists of new and innovative procedures used to treat chronic illnesses such as epilepsy, spasticity, pain, and movement disorders. These disorders can often cause patients significant discomfort and may impact their quality of life. ANS neurosurgeon, Dr. Edward Zampella, is a leading specialist in treating these disorders using functional neurosurgery. These treatments can provide life-altering improvements to an ANS patient’s everyday life.
“The treatment and management of central nervous disorders continues to improve as we learn more about the complexities of the brain,” states Zampella. “Through research and development there is marked progress in the way patients respond to new and innovative treatment options.” Here are a few of the most common diseases of the nervous system treated by Dr. Zampella and ANS:
Vagal nerve stimulators (VNS)
The most profound treatment for epilepsy is vagal nerve stimulators (VNS). This is an augmentative therapy, performed by implanting a device into the body to improve the function of the nervous system. This procedure involves a pacemaker-type implantation with an electrode that is used to essentially “pace” patients out of their symptoms.
Implantable pump therapy
Pain is the most common symptom for which patients seek medical care in the U.S. and can result in negative health consequences, including mental and physical health. “ANS has over 30 years of extensive experience implanting spinal cord stimulation systems for the treatment of chronic pain due either to nervous system injury or failed spine surgery,” says Zampella.
ANS treats pain and spasticity using implantable pump therapy. This therapy involves battery-driven, programmable devices that regulate the amount of medicine being pumped into the body. These devices are so advanced, they can even be programmed to change the amount and time of day the medication is administered.
“This therapy has improved greatly from the original pumps used,” Zampella explains. “Traditional models used expanding gas to regulate the amount of medicine being pumped into the body and any changes in regimen needed to be made manually. Improvements in technology have allowed us to regulate a patient’s needs real time, making treatment more effective.”
Deep Brain Stimulation
Dr. Zampella and other ANS surgeons are trained in deep brain stimulation (DBS). This procedure involves an electrode, similar to a pacemaker, being placed in the brain. The implanted device sends mild electrical signals to an area in the brain that controls movement. This has proven effective in controlling unwanted or disabling motor symptoms. “We are finding that there are medications out there that are causing debilitating side effects for patients. For this reason, many patients are opting for surgically implanted devices like DBS,” states Zampella. “There are even certain stimulations that we have found to give patients complete relief from all of their symptoms.”
To learn more about Dr. Zampella and ANS, visit http://www.ansdocs.com or call 973.285.7800.
BIO: Edward J. Zampella, MD, is recognized as a leader in neurologic surgery in the Northeast region and has been recognized as one of New Jersey’s “Top Docs” in New Jersey Monthly magazine. Dr. Zampella serves as a managing partner of ANS and is a former president of the New Jersey Neurosurgical Society. Board certified in 1991, Dr. Zampella is always well versed about new and innovative procedures that can benefit his patients. Dr. Zampella brought new and innovative technologies into the practice, as well as increased the number of neurosurgeons necessary to deliver access to the many surrounding communities.
For the original version on PRWeb visit: http://www.prweb.com/releases/2014/02/prweb11620903.htm